PluroGen Therapeutics, Inc.

On track to be the 1st topical antibiotic for Diabetic Ulcers approved by FDA, PluroGen specializes in simple solutions for burns and wounds

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Norristown, PA, USA
  • Currency USD
  • Founded December 2005
  • Employees 6
  • Website plurogen.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free